Tenax Therapeutics Meets Nasdaq’s Float Requirement Compliance

Tenax Therapeutics (TENX) has released an update.

Tenax Therapeutics, Inc. has successfully regained compliance with Nasdaq’s Minimum Float Requirement by achieving over 500,000 publicly held shares, a milestone that rectifies their previous non-compliance issue from January 11, 2024. This achievement ensures the company’s continued inclusion on the Nasdaq Capital Market and marks the closure of the matter.

For further insights into TENX stock, check out TipRanks’ Stock Analysis page.